|Podcasts|November 11, 2021
Episode 95: CEOs Share Their Industry Outlook
Author(s)Elaine Quilici, Miranda Schmalfuhs
Advertisement
Jeff Stoll, US Life Sciences Strategy Leader at KPM, talks about some of the highlights from KPMG’s recent Global Pharma CEO Outlook report.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Economics of the 340B Drug Pricing Program: Strategic Imperatives for the Life Sciences Industry in 2026
2
Pharmaceutical Executive Daily: FDA Pilot Targets Faster Early-Stage Drug Trial Starts
3
How 3D Printing Speeds Up Drug Production
4
FDA Pilot Targets Faster Early-Stage Drug Trial Starts
5